Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers

被引:22
|
作者
Chuang, Shu-Chun
Hashibe, Mia
Yu, Guo-Pei
Le, Anh D.
Cao, Wei
Hurwitz, Eric L.
Rao, Jian-Yu
Neugut, Alfred I.
Zhang, Zuo-Feng
机构
[1] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA
[3] Int Agcy Res Canc, Lyon, France
[4] New York Eye & Ear Infirm, Dept Otolaryngol, Biostat & Epidemiol Serv, New York, NY 10003 USA
[5] Univ So Calif, Los Angeles, CA USA
[6] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA
[7] Columbia Univ Coll Phys & Surg, Dept Med & Epidemiol, New York, NY 10032 USA
关键词
thyroid cancer; second cancer; radiation therapy;
D O I
10.1016/j.canlet.2005.06.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although radiation is considered a risk factor for thyroid cancer, the potential relationship between radiation therapy and the risk of second primary cancer among patients with first primary thyroid cancer has not been evaluated. We identified 26,639 patients with first primary thyroid cancer in the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2000. Information on radiation therapy as well as second primary cancers was recorded in SEER. The proportional hazards model was utilized to estimate adjusted risk ratios (RRs) and their 95% confidence intervals (CIs) to assess the potential association between radiation therapy for thyroid cancer and the risk of second primary cancers. With 270,674.33 person-years of follow-up, 1,896 (7.1%) of the 26,639 patients with first primary thyroid cancer developed second primary cancers. Among the second primaries, 35 occurred in the thyroid. No obvious association was observed between radiation therapy and the overall risk of second primary cancer after ten years of follow-up (RR = 1.07, 95% CI = 0.88-1.30). However, an increased risk was seen for several cancers, including upper digestive system cancers (RR = 1.66, 95% CI = 1.07-2.57) and myeloid malignancies (RR=3.26, 95% CI= 1.39-7.67). Radiation therapy was associated with reduced second cancer risks for thyroid cancer (RR = 0.18, 95% CI = 0.04-0.76). Beam radiation might be important to the digestive system, radioactive implants might be associated with the male genital system, radioisotopes might have an effect on myeloid malignancies, and combined beam radiation with radioactive implants or radioisotopes might be related to the increased risk of respiratory system cancers. This study suggests that radiation therapy for patients with first primary thyroid cancer might be associated with an increased risk of developing a second primary cancer in the upper digestive system and second primary myeloid malignancies. Radiation therapy for adult patients with thyroid cancer might be associated with a reduced risk of second primary thyroid cancer. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:42 / 52
页数:11
相关论文
共 50 条
  • [1] Radiotherapy for oral cancer as a risk factor for second primary cancers
    Hashibe, M
    Ritz, B
    Le, AD
    Li, G
    Sankaranarayanan, R
    Zhang, ZF
    [J]. CANCER LETTERS, 2005, 220 (02) : 185 - 195
  • [2] Risk of second primary cancers after radiotherapy for prostate cancer
    Hegemann, N. S.
    Ganswindt, U.
    Engel, J.
    Belka, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S158 - S158
  • [3] Exposure to radiotherapy for first primary cancer as a risk factor for second primary thyroid cancer: A case-control study
    Cuellar Cuellar, Andres Arturo
    Cuellar Rivera, Diana Isabel
    Felipe Fierro-Maya, Luis
    Posso Valencia, Hector
    [J]. ANNALES D ENDOCRINOLOGIE, 2020, 81 (06) : 539 - 544
  • [4] The Risk of Second Cancers After Diagnosis of Primary Thyroid Cancer Is Elevated in Thyroid Microcarcinomas
    Kim, Christopher
    Bi, Xiaofeng
    Pan, Dongsheng
    Chen, Yingtai
    Carling, Tobias
    Ma, Shuangge
    Udelsman, Robert
    Zhang, Yawei
    [J]. THYROID, 2013, 23 (05) : 575 - 582
  • [5] Risk of Second Primary Malignancies After External Beam Radiotherapy for Thyroid Cancer
    Jin, Michael C.
    Qian, Z. Jason
    Megwalu, Uchechukwu C.
    [J]. ANTICANCER RESEARCH, 2022, 42 (03) : 1359 - 1365
  • [6] Is radioiodine treatment for thyroid cancer a risk factor for second primary malignancies?
    Dottorini M.E.
    Salvatori M.
    [J]. Clinical and Translational Imaging, 2013, 1 (3) : 205 - 216
  • [7] Risk estimation of second primary cancers after breast radiotherapy
    Santos, Alexandre M. C.
    Marcu, Loredana G.
    Wong, Chia M.
    Bezak, Eva
    [J]. ACTA ONCOLOGICA, 2016, 55 (11) : 1331 - 1337
  • [8] The Risk of Second Primary Cancers in Prostate Cancer Survivors Treated in the Modern Radiotherapy Era
    Jahreiss, Marie-Christina
    Aben, Katja K. H.
    Hoogeman, Mischa S.
    Dirkx, Maarten L. P.
    de Vries, Kim C.
    Incrocci, Luca
    Heemsbergen, Wilma D.
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [9] Evaluating risk for second primary cancers by radiotherapy technique in prostate cancer survivors.
    Pithadia, Kishan
    Advani, Pragati G.
    Schonfeld, Sara J.
    Withrow, Diana
    Bekelman, Justin E.
    Citrin, Deborah E.
    De Gonzalez, Amy Berrington
    Morton, Lindsay M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] Risk of second primary thyroid cancer in cancer survivors
    Yuan, Yewei
    Sun, Peng
    Xiao, Hualin
    Li, Lingfan
    Li, Junyan
    Ai, Xiang
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):